Corona Remedies IPO Subscription History

As of December 10, 2025, the Corona Remedies IPO has been subscribed 144.54 times overall. The IPO is fully subscribed with strong investor demand indicating extremely high interest.

The Corona Remedies IPO subscription window was open from December 08, 2025 to December 10, 2025. Investors could apply through their demat account or ASBA facility.

The Corona Remedies IPO has a price band of ₹1,008 to ₹1,062 per share, with a lot size of 14 shares. Minimum retail investment: ₹14,112 (lower band) or ₹14,868 (upper band).

The QIB category has been subscribed 293.80 times. QIBs were offered 1,221,729 shares. Strong QIB subscription indicates high institutional confidence.

Retail investors subscribed 30.39 times. Retail was offered 2,139,573 shares. High retail subscription reflects strong small-investor interest.

Overall NII: 220.18×. bNII (>₹10L): 246.67×, sNII (<₹10L): 167.20×. NII includes HNIs and corporate entities investing above ₹2 lakh.

Basis of allotment is on December 11, 2025. Check via the registrar's website, Bigshare Services Private Limited using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.

Corona Remedies IPO is expected to list on December 15, 2025. Shares will list on NSE,BSE. Allotted shares are credited to your demat account 1 business day before listing.

A subscription multiple of 144.54× means investors have bid for 144.54 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares, allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.

Based on the current retail subscription of 30.39×, the estimated allotment probability for retail investors is Low–Moderate. Lottery-based allotment. Retail allotment in oversubscribed IPOs is done by computerised lottery, each valid application has an equal probability regardless of the number of lots applied for.

You can apply for Corona Remedies IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from Dec 08 to Dec 10, 2025.

The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Corona Remedies IPO GMP data, check the IPORise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price. Use it only as a sentiment signal alongside official subscription data.